US CDC Advisory Panel Recommends Pfizer Vaccine for Children Aged 5-11 (Update)

[Image source=AP Yonhap News]

[Asia Economy Reporter Kim Suhwan] The advisory panel of the U.S. Centers for Disease Control and Prevention (CDC) has recommended Pfizer vaccination for children aged 5 to 11.

According to the New York Times (NYT) and the Washington Post (WP) on the 2nd (local time), the CDC's Advisory Committee on Immunization Practices (ACIP), composed of external experts, unanimously recommended Pfizer vaccination for children aged 5 to 11.

Accordingly, once the CDC director gives final approval, vaccination with Pfizer for this age group is expected to begin immediately.

WP reported, "CDC Director Rochelle Walensky is expected to give final approval for Pfizer vaccination for children aged 5 to 11 as early as this afternoon."

Previously, on the 29th of last month, the U.S. Food and Drug Administration (FDA) approved the emergency use of the Pfizer vaccine for children aged 5 to 11.

According to the FDA, the Pfizer vaccine will be administered twice at a three-week interval to children in this age group, with a dose of 10 μg (micrograms), which is one-third of the adult dose (30 μg).

The U.S. government has been preparing a large-scale vaccination plan for children aged 5 to 11 in line with this emergency use authorization.

The White House stated that as of early this week, it has secured enough vaccine doses to vaccinate approximately 28 million children in this age group nationwide.

A senior White House official said yesterday, "Starting from the 8th, large-scale vaccination for children will begin at vaccination sites nationwide."

This content was produced with the assistance of AI translation services.